PTEN and cancer: Alterations in the PI3KCA oncogene and its negative regulator, PTEN, occur in cancers of the colon, breast, and prostate: cancers where the co-occurrence of PI3KCA and PTEN mutations appears to both drive oncogenesis, and reduce anticancer drug sensitivity [10, 42].